"Interferon-gamma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES.
Descriptor ID |
D007371
|
MeSH Number(s) |
D12.644.276.374.440.893 D12.644.276.374.480.615.350 D12.776.467.374.440.893 D12.776.467.374.480.615.350 D23.529.374.440.893 D23.529.374.480.615.350
|
Concept/Terms |
Interferon-gamma- Interferon-gamma
- gamma-Interferon
- Interferon, Immune
- Immune Interferon
- Type II Interferon
- Interferon, Type II
- Interferon Type II
- Interferon, gamma
|
Below are MeSH descriptors whose meaning is more general than "Interferon-gamma".
Below are MeSH descriptors whose meaning is more specific than "Interferon-gamma".
This graph shows the total number of publications written about "Interferon-gamma" by people in this website by year, and whether "Interferon-gamma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 8 | 7 | 15 |
1995 | 4 | 7 | 11 |
1996 | 6 | 10 | 16 |
1997 | 8 | 10 | 18 |
1998 | 3 | 10 | 13 |
1999 | 6 | 9 | 15 |
2000 | 1 | 11 | 12 |
2001 | 5 | 11 | 16 |
2002 | 9 | 17 | 26 |
2003 | 1 | 22 | 23 |
2004 | 11 | 17 | 28 |
2005 | 2 | 22 | 24 |
2006 | 12 | 21 | 33 |
2007 | 5 | 19 | 24 |
2008 | 9 | 30 | 39 |
2009 | 7 | 22 | 29 |
2010 | 4 | 34 | 38 |
2011 | 14 | 19 | 33 |
2012 | 3 | 24 | 27 |
2013 | 2 | 16 | 18 |
2014 | 9 | 18 | 27 |
2015 | 12 | 8 | 20 |
2016 | 8 | 10 | 18 |
2017 | 3 | 16 | 19 |
2018 | 0 | 22 | 22 |
2019 | 6 | 7 | 13 |
2020 | 6 | 11 | 17 |
2021 | 0 | 9 | 9 |
2022 | 1 | 6 | 7 |
2023 | 0 | 3 | 3 |
2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Interferon-gamma" by people in Profiles.
-
Comprehensive characterization of IFN? signaling in acute myeloid leukemia reveals prognostic and therapeutic strategies. Nat Commun. 2024 Feb 28; 15(1):1821.
-
SHP2 promotes sarcoidosis severity by inhibiting SKP2-targeted ubiquitination of TBET in CD8+ T cells. Sci Transl Med. 2023 09 13; 15(713):eade2581.
-
Prolonged cytopenia following CD19 CAR T?cell therapy is linked with bone marrow infiltration of clonally expanded IFN?-expressing CD8 T?cells. Cell Rep Med. 2023 08 15; 4(8):101158.
-
Mapping the functional interactions at the tumor-immune checkpoint interface. Commun Biol. 2023 04 27; 6(1):462.
-
Histiocytic Disorders of Childhood. Pediatr Rev. 2022 Oct 01; 43(10):561-571.
-
Pin-Pointing the Key Hubs in the IFN-? Pathway Responding to SARS-CoV-2 Infection. Viruses. 2022 09 30; 14(10).
-
FGD5 marks a subpopulation of hematopoietic stem and progenitor cells that resist interferon-?-mediated differentiation. Exp Hematol. 2022 Aug-Sep; 112-113:35-43.
-
BHLHE40 Regulates the T-Cell Effector Function Required for Tumor Microenvironment Remodeling and Immune Checkpoint Therapy Efficacy. Cancer Immunol Res. 2022 05 03; 10(5):597-611.
-
Immune phenotype of the CD4+ T cells in the aged lymphoid organs and lacrimal glands. Geroscience. 2022 08; 44(4):2105-2128.
-
Interplay between soluble CD74 and macrophage-migration inhibitory factor drives tumor growth and influences patient survival in melanoma. Cell Death Dis. 2022 02 04; 13(2):117.